Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1995 1
1996 2
2000 2
2002 1
2003 1
2004 3
2005 3
2006 6
2007 5
2008 15
2009 8
2010 9
2011 7
2012 16
2013 6
2014 12
2015 6
2016 8
2017 5
2018 6
2019 11
2020 17
2021 17
2022 9
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Mutational Signatures in Salivary Gland Carcinomas.
Chrysovergis A, Papanikolaou V, Spyropoulou D, Roukas D, Asimakopoulos AD, Papanastasiou G, Mastronikoli S, Falidas E, Papouliakos S, Tsiambas E, Pantos P, Ragos V, Peschos D, Mastronikolis N, Kyrodimos E. Chrysovergis A, et al. Among authors: papanikolaou v. Cancer Diagn Progn. 2023 Jul 3;3(4):411-415. doi: 10.21873/cdp.10233. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405215 Free PMC article. Review.
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma.
Papanikolaou V, Kyrodimos E, Mastronikolis N, Asimakopoulos AD, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, Pantos P, Ragos V, Peschos D, Chrysovergis A. Papanikolaou V, et al. Cancer Diagn Progn. 2023 Mar 3;3(2):151-156. doi: 10.21873/cdp.10194. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875315 Free PMC article. Review.
Micro-RNAs signatures in papillary thyroid carcinoma.
Mastronikolis N, Tsiambas E, Roukas D, Fotiades P, Chrysovergis A, Papanikolaou V, Kyrodimos E, Mastronikoli S, Niotis A, Ragos V. Mastronikolis N, et al. Among authors: papanikolaou v. J BUON. 2020 Sep-Oct;25(5):2144-2146. J BUON. 2020. PMID: 33277828 Free article. Review.
c-Jun/c-Fos complex in laryngeal squamous cell carcinoma.
Tsiambas E, Mastronikolis N, P Fotiades P, Kyrodimos E, Chrysovergis A, Papanikolaou V, Mastronikolis S, Peschos D, Roukas D, Ragos V. Tsiambas E, et al. Among authors: papanikolaou v. J BUON. 2020 Mar-Apr;25(2):618-620. J BUON. 2020. PMID: 32521843 Free article. Review.
169 results